Carla Thiciane Vasconcelos de  Melo

Dr. Carla Thiciane Vasconcelos de Melo

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2011 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
CMCarla Thiciane Vasconcelos de Melo
Carla Thiciane Vasconcelos de Melo
ACAlyne Mara Rodrigues de Carvalho
Alyne Mara Rodrigues de Carvalho
BMBrinell Arcanjo Moura
Brinell Arcanjo Moura
CTCaroline Porto Leite Teixeira
Caroline Porto Leite Teixeira
LVLeonardo Freire Vasconcelos
Leonardo Freire Vasconcelos
FSFrancisca Cléa Florenço de Sousa
Francisca Cléa Florenço de Sousa

27 June 2018 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
MPMichele Sanford Rangel Parente
Michele Sanford Rangel Parente
FCFeliphy Rodrigues Custódio
Feliphy Rodrigues Custódio
NCNayara Cardoso
Nayara Cardoso
MLMárcia Jordana Araújo Lima
Márcia Jordana Araújo Lima
TMTiago Sousa de Melo
Tiago Sousa de Melo
CMCarla Thiciane Vasconcelos de Melo
Carla Thiciane Vasconcelos de Melo
Depression is a common disease affecting more than 300 million people worldwide. Since Lippia sidoides has shown central nervous system effects in previous works, we aimed to investigate the effect of L. sidoides essential oil and its major compound, thymol on a corticosterone-induced depression model in mice. Male mice (20–25 g) received corticosterone (20 mg/kg, subcutaneously), once a day for 22 days. From the 16th day on, mice were grouped to receive either corticosterone or L. sidoides essential oil (100 and 200 mg/kg), or thymol (25 and 50 mg/kg) or fluoxetine (35 mg/kg) by gavage. The forced swimming test, tail suspension, open field, elevated plus maze and sucrose preference tests were performed from the 19th to 22nd day. Data were analyzed by ANOVA followed by the Student-Newman-Keuls as a post hoc test and the results were considered significant when p < 0.05. It was shown that L. sidoides essential oil, thymol and fluoxetine decreased the immobility time in the tail suspension and forced swimming tests and none of these altered locomotor activity in the open field test. However, the drugs increased the amount of grooming. In the elevated plus maze, all drugs increased the number of entries and the time of permanence in the open arms. In the sucrose preference test, the L. sidoides essential oil, thymol and fluoxetine reversed anhedonia. These results suggest that the thymol and L. sidoides essential oil have an antidepressant-like effect, similar to fluoxetine. However, future studies should be encouraged to enhance understanding of the effects of essential oil and thymol for the treatment of depression.

19 May 2026 in bioRxiv
Verified
Preprint
Open access
MPManoel C. de Paulo
Manoel C. de Paulo
LALissiana M.V. Aguiar
Lissiana M.V. Aguiar
NFNívea M. Cunha Ferreira
Nívea M. Cunha Ferreira
JNJordana M. Nascimento
Jordana M. Nascimento
LRLeonardo Resstel
Leonardo Resstel
CMCarla Thiciane Vasconcelos de Melo
Carla Thiciane Vasconcelos de Melo
Background: Lauric acid (LA) is a medium-chain saturated fatty acid found in several foods, including vegetable oils and seeds. Previous studies have demonstrated that LA exhibits neuroprotective, antioxidant, and anti-inflammatory properties in experimental models of neuropsychiatric disorders. Therefore, the present study aimed to investigate the behavioral and neurochemical effects of LA in a corticosterone-induced murine model of depression. Methods: Male Swiss mice received corticosterone (CORT; 20 mg/kg, subcutaneously) for 23 consecutive days, while the control group received vehicle only. During the last nine days of the experimental protocol, the animals received the respective treatments by oral gavage: LA (10 or 20 mg/kg), fluvoxamine (FLUV; 50 mg/kg), or vehicle, administered 1 hour after CORT injection. One hour after treatment administration, the animals were subjected to the behavioral tests: Forced Swimming Test (FST), Tail Suspension Test (TST), and Open Field Test (OFT). At the end of the experimental protocol, the animals were euthanized, and the prefrontal cortex (PFC), hippocampus (HPC), and striatum (STR) were collected for neurochemical analyses. Results: Chronic CORT treatment significantly increased immobility time in the FST and TST, characterizing depressive-like behavior. Treatment with LA reversed these behavioral alterations, showing an effect similar to that observed in the FLUV-treated group. In the OFT, LA did not promote significant changes in locomotor activity, suggesting the absence of psychostimulant effects. Regarding neurochemical analyses, LA treatment did not reduce malondialdehyde (MDA) or nitrite/nitrate (NO 2 − /NO 3 − ) levels, nor did it alter reduced glutathione (GSH) levels in the evaluated brain regions. Conclusion: The results demonstrated that LA treatment was able to reverse corticosterone-induced behavioral alterations in mice, indicating a potential antidepressant-like effect. Furthermore, the observed effects were not associated with nonspecific locomotor alterations. Although LA did not promote significant changes in the evaluated neurochemical markers, these findings reinforce its potential as a therapeutic agent for depressive disorders and highlight the need for further studies to elucidate its mechanisms of action and possible clinical applicability.